title: Combination pirfenidone and inhaled N-acetylcysteine therapy for IPF: does it take these two to tango?
authors: Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA; Audie L. Murphy VA Hospital, South Texas Veterans Health Care System, San Antonio, Texas, USA.
authors: Maria I
authors: MI
authors: Velez
authors: Anoop M
authors: AM
authors: Nambiar
mesh_terms: D000111:Acetylcysteine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy*; D008297:Male; D011728:Pyridones / Q000008:administration & dosage*
chemical_list: D011728:Pyridones; D000111:Acetylcysteine
keywords: acetylcysteine; combination drug therapy; disease progression; idiopathic pulmonary fibrosis; pirfenidone